Chromium (Chromium Picolinate) Simply Explained
Chromium is a trace element that in research is mainly associated with sugar metabolism. This page explains in simple words what studies in humans show — and what remains open.
1. What It Is About
Chromium is a trace element. The body needs it only in very small amounts. In research, chromium almost always appears in connection with sugar metabolism, that is, how the body absorbs and processes sugar from the blood. In most studies, chromium was given as chromium picolinate. This is a compound of chromium and picolinic acid, a metabolite of tryptophan, an amino acid. Many papers, however, speak only generally of chromium supplementation without naming the exact compound. The central idea of the field stems from a single observation: In a patient who had been artificially nourished for a long time, a sugar metabolism disorder and nerve damage improved when he received chromium. From this arose the assumption that a lack of chromium impairs the effect of insulin. Insulin is the hormone that brings sugar from the blood into the cells. This assumption still shapes every study today. Because if chromium works primarily in the case of a deficiency, it depends on whether the people studied had too little of it at all.
2. What Studies Show
Chromium is best studied in people with type 2 diabetes and insulin resistance. Insulin resistance means: the body responds less well to insulin. A randomised, double-blind study with 180 people with type 2 diabetes divided the participants into three groups: a placebo and two different doses of chromium as chromium picolinate, over four months. Medications and lifestyle remained unchanged. In the group with the higher dose, fasting blood sugar was lower after two and after four months, as was blood sugar two hours after eating. Randomised means: chance decides who gets which group. Double-blind means: neither participants nor practitioners know who receives what. 9 A further randomised, double-blind study followed 64 people with type 2 diabetes and coronary heart disease for twelve weeks. Observed were a slight reduction in weight and body mass index, lower fasting blood sugar, less insulin in the blood and better insulin sensitivity. An inflammation marker and a marker for oxidative stress also decreased. The study is small, but it examined many different values simultaneously. 6 A third randomised, double-blind study tested a mixture of chromium picolinate and biotin against a placebo in 348 people with type 2 diabetes over 90 days. The long-term blood sugar value HbA1c and blood sugar decreased. Because two substances were given together here, it is not possible to determine what chromium alone achieved. 7 In women with polycystic ovary syndrome, a hormone disorder with irregular cycles, an evaluation of five randomised studies summarised that chromium picolinate lowered body mass index and fasting insulin and increased the chance of ovulation. 5 Not always was an effect seen. A large evaluation of 20 randomised studies with 618 participants found no association between chromium and sugar or insulin values in people without diabetes. 1
3. What Remains Unclear
The results vary from study to study. An evaluation of ten randomised studies with 509 patients found a difference only in HbA1c, not in blood lipids or fasting blood sugar. 2 Two evaluations on blood pressure reached opposing results: one saw a slight reduction, the other did not. 3 4 Often several substances were given together — chromium with magnesium, chromium with biotin, chromium in a mixture of several plant substances. 11 7 10 From such mixtures, no effect of chromium alone can be derived. The question of which chromium compound was tested also remains open: chromium picolinate, chromium chloride, chromium dinicocysteinate, chromium yeast and brewer’s yeast were used differently in the papers, and no evaluation separates them cleanly. A study on atypical depression with 113 adults found no difference from placebo. 8
4. What This Means in Everyday Life
Chromium is a trace element that the body needs in small amounts. The idea behind the research is: chromium works where it is lacking. This idea stems from the observation in a single patient who was artificially nourished and whose sugar metabolism improved under chromium supplementation. Whether such a deficiency can be reliably detected in humans remains open to this day. This explains why the studies turn out so differently. If one does not know whether the participants had too little chromium at all, a null finding cannot be distinguished from a missing prerequisite. A measurement value on which the papers uniformly rely is still lacking. What would need to be clarified next: a large, independently funded study that tests a single chromium compound, determines chromium status beforehand and evaluates the participants grouped accordingly.
All Details with Study Numbers and Sources: detailed page on Chromium (Chromium Picolinate). For Children: Chromium (Chromium Picolinate) for Children.
Frequently Asked Questions
Does chromium lower blood sugar?
In several analyses, fasting glucose and insulin decreased in people with type 2 diabetes. In people without diabetes, one large analysis showed no association. The results depend strongly on which people were studied.
Is chromium a medicine?
No, chromium is a trace element that is obtained through food. In the studies it was given as a preparation, usually as chromium picolinate. Whether additional intake changes anything when there is no deficiency is the open question in the field.
Why are the studies so different?
The participants were very diverse: some with type 2 diabetes, some overweight without diabetes, some healthy. The chromium compounds tested and the observation periods also differed. That is why the results are difficult to combine into one picture.
Sources
- 1Althuis MD, Jordan NE, Ludington EA, Wittes JT · 2002
- 2Zhao F, Pan D, Wang N, Xia H, Zhang H, Wang S et al. · 2022
- 3Lari A, Fatahi S, Sohouli MH, Shidfar F · 2021
- 4Ghanbari M, Amini MR, Djafarian K, Shab-Bidar S · 2022
- 5Heshmati J, Omani-Samani R, Vesali S, Maroufizadeh S, Rezaeinejad M, Razavi M et al. · 2018
- 6Farrokhian A, Mahmoodian M, Bahmani F, Amirani E, Shafabakhsh R, Asemi Z · 2020
- 7
- 8
- 9Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J et al. · 1997
- 10Derosa G, D'Angelo A, Vanelli A, Maffioli P · 2020
- 11Dou M, Ma Y, Ma AG, Han L, Song MM, Wang YG et al. · 2016
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.